spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  SABER 

 HSMN NewsFeed - 6 Dec 2023
NSite Medical Announces FDA Clearance for Groundbreaking AI-Based Scoliosis Scanning App
Devices FDA
 HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 10 Mar 2022
S.M.A.R.T. RADIANZ(TM) Vascular Stent System Approved for Transradial Use in the U.S.
Devices Interventional FDA
 HSMN NewsFeed - 2 Feb 2021
DURECT Corporation Announces U.S. FDA Approval of POSIMIR(R) For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Jan 2021
DURECT Corporation Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Jan 2020
DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR(R)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Oct 2019
DURECT Announces FDA Advisory Committee Meeting to Review POSIMIR(R) for the Treatment of Post-Surgical Pain
Biopharmaceuticals Drug Delivery Surgery FDA
 HSMN NewsFeed - 27 Jun 2019
DURECT Announces Submission to FDA of a Full Response to the POSIMIR(R) Complete Response Letter
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Jun 2019
DURECT Announces $15 Million Registered Direct Offering
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 25 Apr 2019
DURECT Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 19 Dec 2018
Commercial Launch Plans Announced for PERSERIS(TM) (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 9 May 2018
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR(R) (SABER(R)-Bupivacaine)
Biopharmaceuticals Drug Delivery Surgery Licensing
 HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2017
DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR(R)
Biopharmaceuticals
 HSMN NewsFeed - 22 Sep 2015
Invuity(R) Introduces Eiberg(TM) Illuminated Retractor System With Integrated Intelligent Photonics(TM) To Orthopedic Market
Devices Surgery Product Launch
 HSMN NewsFeed - 19 Nov 2014
Cordis Corporation Leads With Strong Podium Presence At VEITH 2014 With First-Ever Presentation Of Three-Year INCRAFT(R) System Data
Devices Interventional
 HSMN NewsFeed - 7 Jan 2014
Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 22 Oct 2013
Pfizer Proceeding with REMOXY(R) Development
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 27 Sep 2013
DURECT Announces Changes to its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 20 Jun 2013
DURECT Announces FDA Acceptance of New Drug Application (NDA) Submission for POSIDUR(R) (SABER(R)-Bupivacaine)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 19 Apr 2010
Covidien Announces Innovation: Delivered Mobile Surgical Tour
Devices Surgery
 HSMN NewsFeed - 19 Jan 2010
DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2009
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2007
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Sep 2007
Integra LifeSciences Launches Bone-Cutting Selector SaberTip At 2007 Congress of Neurological Surgeons Meeting
Devices Neurosurgery
 HSMN NewsFeed - 29 Jan 2007
DURECT Signs POSIDUR(TM) Manufacturing Agreement with Hospira
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2006
DURECT and Nycomed Sign $202 Million Agreement to Develop and Commercialize POSIDUR(TM) in Europe and Other Select Countries
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 31

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 31 additional stories matching:
SABER
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.